Multidrug‐Resistant and Extensively Drug‐Resistant Tuberculosis: The National Institute of Allergy and Infectious Diseases Research Agenda and Recommendations for Priority Research-Reference-Cited by-同舟云学术

Multidrug‐Resistant and Extensively Drug‐Resistant Tuberculosis: The National Institute of Allergy and Infectious Diseases Research Agenda and Recommendations for Priority Research

Published:2008-06 Issue:11 Volume:197 Page:1493-1498
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:J INFECT DIS

Author:

Fauci Anthony S.,

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/197/11/1493/18050364/197-11-1493.pdf

Reference24 articles.

1. World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO report 2008. Available at: http://www.who.int/tb/publications/global_report/2008/pdf/fullreport.pdf. Accessed 28 March 2008.

2. Joint United Nations Programme on HIV/AIDS (UNAIDS), World Health Organization. AIDS epidemic update: November 2007. Available at: http://www.unaids.org/en/KnowledgeCentre/HIVData/EpiUpdate/EpiUpdArchive/2007/default.asp. Accessed 28 March 2008.

3. World Health Organization. XDR TB-extensively drug-resistant TB, November 2006: outcomes of the WHO Global Task Force on XDR TB, October 9-10. Available at: http://www.who.int/tb/xdr/xdr_nov06_en.pdf. Accessed 28 March 2008.

4. World Health Organization. Tuberculosis fact sheet. Available at: http://www.who.int/mediacentre/factsheets/fs104/en/index.html. Accessed 28 March 2008.

Cited by 95 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anti-Tuberculosis Potential of OJT008 against Active and Multi-Drug-Resistant Mycobacterium Tuberculosis: In Silico and In Vitro Inhibition of Methionine Aminopeptidase;International Journal of Molecular Sciences;2023-12-05

2. An intranasal stringent response vaccine targeting dendritic cells as a novel adjunctive therapy against tuberculosis;Frontiers in Immunology;2022-09-16

3. An intranasal stringent response vaccine targeting dendritic cells as a novel adjunctive therapy against tuberculosis;2022-04-19

4. Adjunctive interleukin-2 for the treatment of drug-susceptible tuberculosis: a randomized control trial in China;Infection;2021-09-25

5. Rifampicin resistance patterns and dynamics of tuberculosis and drug-resistant tuberculosis in Enugu, South Eastern Nigeria;The Journal of Infection in Developing Countries;2020-09-30